Decoding the Present and Future of Biologics CDMO: Cheng Zengjiang in Dialogue with Zhou Kaisong of CBP (Innovent Biologics)

May 16,2026

"We are like the Sherpas – carrying luggage, guiding the way, helping others reach the summit."

GSK in Transition: Perfect, It’s Chinese Innovative Drugs

May 15,2026

Targeting £40 billion in revenue

End of a Chaotic Tenure: FDA Commissioner Steps Down After 14 Months

May 14,2026

The Makary Era Ends: Is FDA’s Turmoil Over?

International Attendee Guide: Visas, Payments, and 1-on-1 Matchmaking

May 13,2026

Attendee Guide for International Participants

After Daiichi Sankyo’s ADC Misstep

May 13,2026

Where will the next blockbuster conjugate drug emerge?

CPIC 2026 | The First Batch of 40+ Youth Co-Creation Partners Has Been Assembled!

May 12,2026

This July, head to the National Exhibition and Convention Center (Shanghai) and do something different.

Pharma R&D Spending TOP 15: Global vs. Domestic

May 12,2026

Merck & Co.'s R&D spending is almost equivalent to the total of China's top 15 pharmaceutical companies combined.
< 1...151617...26 > proceed page